The new drug-creation method could allow cancer drugs to last longer in the body to attack tumors, as well as cancer cells floating in the blood stream.
Indiana University honored UNC neuroscientist Garret Stuber, PhD, for his work uncovering how brain circuits work.
An international consortium of researchers conducted the largest-ever CF genome-wide analysis to find new therapeutic targets.
A science class captured Catherine Fahey’s imagination. A mother’s battle with cancer led her to pursue medicine as a career. At UNC, Fahey found a home at the junction of research and patient care.
Participants in stage III renal cell cancer drug trials are younger and healthier than many patients who don’t qualify for research studies.
UNC Lineberger Comprehensive Cancer Center researchers and eight other leading cancer research institutions have won a five-year, $12 million grant to try to find treatments for a group of cancers linked to mutations in the NF1 gene.
Researchers from Norway visited the cancer center last week to learn firsthand about UNCseq, a clinical trial launched in 2011 at the N.C. Cancer Hospital. In the trial, researchers use a profile of the genetic and molecular alterations in patients' tumors to try to identify targeted treatments for them.
UNC School of Medicine faculty head to Washington to support research cause.
UNC is one of multiple new sites to join the Mid-South Clinical Data Research Network (CDRN), a collaborative partnership that is harnessing data from electronic health records to improve outcomes for patients throughout the Southeast. The expansion is funded by a three-year, $8.5 million funding award from the Patient-Centered Outcomes Research Institute (PCORI).
An $11.3 million, five-year grant from the National Cancer Institute will fund four studies by researchers with the Carolina Center of Cancer Nanotechnology Excellence.
A new UNC School of Medicine study visualizes the dramatic influence of a diabetes drug on bone health and the benefit of exercise in mice.
A UNC Lineberger-led study, published today in Nature Genetics, paves the way for potential personalized medicine approaches for the deadly cancer type.
A new research brief published by the Cecil G. Sheps Center for Health Science Research finds that North Carolina does have enough physicians to meet the needs of the state's population, but there is still work to do encouraging doctors to practice in specialties and communities with physician shortages. Erin Fraher, PhD, MPP, assistant professor in family medicine, is a co-author of the brief.
While searching for the purpose of rare plants in a remote South Pacific village, Timothy Platts-Mills, MD, took up the cause of medicine. Now, he’s training the next generation of ED doctors at UNC.
Temperance Rowell delves into the flavored world of e-cigarettes to investigate the long-term effects of a new trend.
The American Society of Hematology fills gap in decreased federal funding, supports 13 blood research projects.
The editors of the MIT Technology Review highlighted Gu’s work on a novel way to monitor and treat diabetes.
New study in Diabetes Care suggests new delayed-release metformin could help 40 percent of type 2 diabetes patients that currently can’t take metformin.
UNC’s part in the study is led by Dr. Cynthia M. Bulik, Distinguished Professor of Eating Disorders in the Department of Psychiatry in the School of Medicine, a Professor of Nutrition in the Gillings School of Global Public Health, and Founding Director of the UNC Center of Excellence for Eating Disorders.
In an article published in JAMA Oncology today, a study led by UNC Lineberger's Ethan Basch and colleagues shows that a system they developed accurately and reliably captures the patient experience with cancer drug side effects.